Our team aim to understand the regulation of type I toxin-antitoxin systems and hijack these systems for therapeutic purposes. More precisely, our research focuses on the regulation of gene expression at the post-transcriptional level. We are interested in understanding how small regulatory RNAs and ribonucleases affect gene expression and virulence in pathogenic bacteria using microbial genetics and RNA sequencing techniques.